Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops Wearable Medical Alert System for Individuals with Heart Disease (TRO-300)

PITTSBURGH, Aug. 5, 2020 /PRNewswire/ -- It's been proven over and over again that time is of the essence when someone experiences the signs of a heart attack. With that in mind, an inventor from Mississauga, Ontario, has come up with a device that can provide a quick, life-saving response to signs of a heart attack.

He developed CODE BLUE ALERT PENDANT, patent-pending, to afford immediate access to aspirin and medical assistance in such cases. By sending the location of the patient to emergency medical services, it has the potential to prevent serious heart damage and deaths. Lightweight, compact and portable, this novel device not only saves time and effort, it is also easy to use. In addition, users will appreciate how convenient, effective and affordably priced it is.

The inventor's personal observation inspired the idea. "I realized it takes too long to find and take aspirin and then call for help in the event of a heart attack," he said. "This device will reduce response time significantly."

The original design was submitted to the Toronto sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-TRO-300, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp

These press releases may also interest you

at 14:38
Baylor College of Medicine and The Menninger Clinic jointly announce the hiring of Robert J. Boland, M.D., as vice chairman of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine and chief of staff at The...

at 14:21
Columbus-based STARK Industries, LLC has contributed to a new exhibit at Space Center Houston, highlighting?how NASA continues?to innovate to overcome obstacles and benefit humanity during the COVID-19 pandemic. NASA's Jet Propulsion Laboratory in...

at 14:15
The "Enteral Feeding Formulas Market Size, Share & Trends Analysis by Product (Standard Formula, Disease-specific Formula), by Flow Type, by Stage, by Indication, by End User, and Segment Forecasts, 2020 - 2027" report has been added to...

at 14:12
Raphael K. Osei, MD, is being recognized by Continental Who's Who as a Leading Obstetrician-Gynecologist for his outstanding contributions in the field of Medicine and acknowledgment of his steadfast devotion with Cornerstone Family Healthcare at...

at 14:10
Crystal IS, an Asahi Kasei company, and Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) have performed research demonstrating the efficacy of Crystal IS' Klaran UVC LEDs to inactivate SARS-CoV-2. Crystal IS initiated...

at 14:10
Applied Biology in collaboration with researchers at University Hospital Ramon y Cajal in Madrid, Spain, today announced results from their androgen receptor genetics study in hospitalized COVID-19 male patients (NCT04368897,...

News published on 5 august 2020 at 11:45 and distributed by: